Pharmacology | Pharmacology Mentor

Pharmacology of Levocetirizine

Introduction Levocetirizine is a widely used second-generation H1-antihistamine, often prescribed for the management of allergic rhinitis, urticaria, and other allergic conditions. It is the active R-enantiomer of its racemic counterpart, cetirizine, a drug that has…

Pharmacology Mentor December 18, 2023

Antimicrobial Pharmacology

Pharmacology of Linezolid

Linezolid is a synthetic oxazolidinone antibiotic indicated for serious Gram-positive bacterial infections, including those caused by methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant Enterococcus faecium (VRE), and penicillin-resistant Streptococcus pneumoniae. It is…

Pharmacology Mentor December 18, 2023

Hematology Pharmacology

Pharmacology of Rivaroxaban

Introduction Rivaroxaban is an oral direct Factor Xa inhibitor widely used for the prevention and treatment of thromboembolic disorders. Developed as part of a newer generation of target-specific oral anticoagulants (TSOACs) or direct oral anticoagulants (DOACs), rivaroxaban offers…

Pharmacology Mentor December 18, 2023

Antimicrobial Pharmacology

Pharmacology of Vancomycin

Introduction Vancomycin is a prominent glycopeptide antibiotic widely recognized for its efficacy in treating severe infections caused by Gram-positive bacteria, particularly methicillin-resistant Staphylococcus aureus (MRSA) and certain Clostridioides difficile (C.…

Pharmacology Mentor December 18, 2023

GI Pharmacology

Inflammatory Bowel Disease (IBD)

Introduction Inflammatory Bowel Disease (IBD) is a chronic, relapsing-remitting inflammatory disorder of the gastrointestinal tract that primarily includes Crohn’s disease (CD) and ulcerative colitis (UC). Both conditions can produce significant…

Pharmacology Mentor November 21, 2023

GI Pharmacology

Irritable Bowel Syndrome (IBS)

Introduction Irritable Bowel Syndrome (IBS) is a chronic functional gastrointestinal disorder characterized by abdominal pain and altered bowel habits in the absence of any identifiable structural or biochemical abnormalities. IBS…

Pharmacology Mentor November 21, 2023

GI Pharmacology

Gastroesophageal Reflux Disease (GERD)

I. Introduction Gastroesophageal reflux disease (GERD) is a chronic disorder characterized by the reflux of gastric contents into the esophagus, which leads to troublesome symptoms, mucosal injury, and, in some cases,…

Pharmacology Mentor November 21, 2023

GI Pharmacology

Peptic Ulcer Disease (PUD) – A brief note

Introduction Peptic Ulcer Disease (PUD) is a gastrointestinal disorder characterized by sores or lesions in the lining of the stomach or duodenum. It is a significant health concern worldwide, affecting…

Pharmacology Mentor November 21, 2023

GI Pharmacology

Helicobacter pylori Infection and Treatment

Introduction Helicobacter pylori (H. pylori) is a spiral-shaped, gram-negative bacterium that colonizes the human stomach and duodenum. First identified in the early 1980s, this organism quickly garnered attention due to its…

Pharmacology Mentor November 21, 2023

GI Pharmacology

Zollinger-Ellison Syndrome (ZES)

I. Definition, Historical Perspective & Epidemiology Zollinger–Ellison Syndrome (ZES) is a rare disorder characterized by gastrin-secreting tumors (“gastrinomas”) of the pancreas or duodenum. These tumors lead to excessive gastric acid secretion,…

Pharmacology Mentor November 21, 2023

Pharmacology of Levocetirizine

Pharmacology of Linezolid

Pharmacology of Rivaroxaban

Pharmacology of Vancomycin

Inflammatory Bowel Disease (IBD)

Irritable Bowel Syndrome (IBS)

Gastroesophageal Reflux Disease (GERD)

Peptic Ulcer Disease (PUD) – A brief note

Helicobacter pylori Infection and Treatment

Zollinger-Ellison Syndrome (ZES)

Pharmacology Tools

Medical Tools